Advertisement
Journal Home
Search for

Volume 42, Issue 3, Pages 196-200 (March 2010)


View previous. 8 of 20 View next.

Value of Brain Magnetic Resonance Imaging in Mitochondrial Respiratory Chain Disorders

Luísa Diogo, MD§Corresponding Author Informationemail address, Miguel Cordeiro, MD, Paula Garcia, MD, Isabel Fineza, MD, Cristina Moura, MD, Catarina Resende Oliveira, MD, PhD§, Margarida Veiga, BSc, Teresa Garcia, MD, Manuela Grazina, PhD§

Received 24 March 2009; accepted 23 September 2009.

Mitochondrial respiratory chain (MRC) disorders have variable clinical manifestations which are mainly neurologic. Diagnosis in children is more complex than in adults because the classic phenotype, ragged red fibers, and mtDNA mutations are rarely seen in children. Moreover, clinical manifestations of disease in developing brains are less explicit. Although not specific, neuroimaging may be contributory to the diagnosis of these disorders in pediatric patients. Brain magnetic resonance images were reviewed for 133 pediatric patients investigated for a MRC disorder at a single center over a period of 10 years (1997-2006), in an attempt to identify distinctive neuroimaging features of MRC defects. Patients fit into four groups, according to the Bernier criteria: definite (63 cases), probable (53 cases), possible (7 cases) and unlikely diagnosis (10 cases). Brain atrophy (41 cases), supratentorial white matter lesions (14 cases), basal ganglia involvement (9 cases), and delayed myelination (9 cases) were the most frequent anomalies in the definite group, and 8 patients presented Leigh syndrome. Neuroimaging findings of the 63 children in the definite group were compared with the remainder and with those in the possible and unlikely groups. There were no significant differences in brain images between the groups analyzed, and therefore no distinctive brain imaging features were identified specific for MRC disorders.

 Metabolic Diseases Unit, Luís Borges Center for Child Development, Pediatric Hospital of Coimbra-CHC EPE, Coimbra Portugal

 Neuroradiology Department, University Hospital of Coimbra, Coimbra, Portugal

 Faculty of Medicine, University of Coimbra, Coimbra, Portugal

§ Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal

 Statistics Division, Portuguese League Against Cancer, Coimbra, Portugal

 Neuroradiology Department, General Hospital-CHC EPE, Coimbra, Portugal

Corresponding Author InformationCommunications should be addressed to: Dr. Diogo; Unidade de Doenças Metabólicas; Centro de Desenvolvimento da Criança Luís Borges; Hospital Pediátrico de Coimbra-CHC EPE; Av. Bissaya Barreto; 3000-076 Coimbra, Portugal.

PII: S0887-8994(09)00482-2

doi:10.1016/j.pediatrneurol.2009.09.010


View previous. 8 of 20 View next.

Advertisement